Group 1 - The core point of the announcement is that the shareholder Guoshou Chengda (Shanghai) Health Industry Equity Investment Center (Limited Partnership) has reduced its stake in Jiahe Meikang (Beijing) Technology Co., Ltd. by 301,797 shares, bringing its total holdings down from 16,812,069 shares to 16,510,272 shares, which represents a decrease from 12.22% to 12.00% of the company's total share capital, thus triggering a 1% threshold [2][4] - The reduction occurred between May 26, 2025, and June 5, 2025, through centralized bidding, and the reduction plan is still ongoing [2][3] - This equity change does not trigger a mandatory tender offer and is part of a previously disclosed reduction plan, ensuring that the company's governance structure and ongoing operations remain unaffected [2][3]

本公司董事会及全体董事保证公告内容与信息披露义务人提供的信息 一致。 证券代码：688246 证券简称：嘉和美康 公告编号：2025-039 嘉和美康（北京）科技股份有限公司 关于持股 5%以上股东权益变动触及 1%刻度的提示性 公告 股东国寿成达（上海）健康产业股权投资中心（有限合伙）保证向本 公司提供的信息真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 | 投资者名称 | 变动前股数 | 变动前比例 | 变动后股数 | 变动后比例 | 权益变动方 | 权益变动的 | | --- | --- | --- | --- | --- | --- | --- | | | （万股） | （%） | （万股） | （%） | 式 | 时间区间 | | 发生直接持股变动的主体： | | | | | | | | 国寿成达（上 海）健康产业 股权投资中 心（有限合 | 1681.2069 | 12.22 | 1651.0272 | 12.00 | ☑集中竞价 □大宗交易 其 他 ： ____ | 2025/05/26- 2025/06/05 | | 伙） | | | | | （请注明） | | | 合计 | 168 ...

证券代码：688246 证券简称：嘉和美康 公告编号：2025-038 嘉和美康（北京）科技股份有限公司 关于公司恢复原投资者联系电话的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 嘉和美康（北京）科技股份有限公司（以下简称"公司"）原投资者热线已 于近日安装完成并恢复使用。除投资者联系电话恢复外，公司其他联系方式均保 持不变，现将公司最新联系方式公告如下： 投资者联系方式： 1、办公地址：北京市海淀区东北旺西路 8 号院 28 号楼 1 层 101 2、邮政编码：100193 3、投资者联系电话：010-82781910 4、联系电子邮箱：zqb@bjgoodwill.com 上述联系电话自本公告发布之日起正式启用，临时投资者联系电话自本公告 发布之日起停用，敬请投资者注意。 特此公告。 嘉和美康（北京）科技股份有限公司董事会 2025 年 5 月 29 日 ...

嘉和美康(北京)科技股份有限公司 2025 年度"提质增效重回报"行动方案 为积极响应上海证券交易所《关于开展科创板上市公司"提质增效重回报" 专项行动的倡议》，践行以"投资者为本"的上市公司发展理念，维护嘉和美康(北 京)科技股份有限公司（以下简称"公司"）全体股东特别是广大中小投资者利 益，公司制定了 2025 年度"提质增效重回报"行动方案，以进一步提升公司经 营效率，强化市场竞争力，保障投资者权益，树立良好的资本市场形象。具体方 案如下： 一、聚焦主业发展，不断提升公司竞争力 公司是国内最早从事医疗信息化软件研发与产业化的企业之一，深耕临床信 息化领域，在此领域内拥有长期的领先优势，公司在电子病历细分领域市场连续 10 年排名全国第一，在医疗大数据应用领域市场连续 5 年排名全国前三。公司 现有主要产品及服务包括医疗临床、运营管理、医疗数据、生命科学等业务板块， 各板块产品协同应用，形成全面支撑智慧医院建设的二十余种解决方案。此外， 公司还面向区域型用户提供县域医共体、城市医疗集团及云电子病历等区域医疗 解决方案。 2024年，公司实现营业收入59,194.43万元，较上年同期收入减少了14.85%， ...

Investment Rating - The report maintains a "Buy" rating for several companies in the AI and computing sector, including Yidao Information, iFlytek, Weike Technology, and others, indicating a positive outlook for their stock performance [13][48]. Core Insights - The AI sector is experiencing significant advancements, particularly with the launch of Claude 4 models, which enhance coding and reasoning capabilities, marking a new era in AI applications [3][20]. - The introduction of the Skywork Super Agents by Kunlun Wanwei signifies a breakthrough in AI office applications, showcasing unique features that differentiate it from competitors [5][27]. Summary by Sections 1. Computing Power Dynamics - The rental prices for computing power remain stable, with specific rates for various configurations such as A100-40G and A100-80G [19][21]. - The Claude 4 model was launched on May 23, featuring two variants: Claude Opus 4 and Claude Sonnet 4, both of which demonstrate significant improvements in performance and accuracy [20][22]. 2. AI Application Dynamics - Gemini's average access volume increased by 4.51% week-on-week, indicating growing user engagement in AI applications [26]. - The Skywork Super Agents were released, offering comprehensive capabilities for content creation and task management, thus enhancing productivity in AI office environments [27][30]. 3. AI Financing Trends - Airwallex secured $300 million in Series F funding, raising its valuation to $6.2 billion, reflecting strong market confidence in its global expansion strategy [35][36]. - The funding round included participation from notable investors, indicating a robust interest in the company's growth potential [35][37]. 4. Market Review - The AI computing index and application index showed fluctuations, with notable gains in specific companies like Kunlun Wanwei, highlighting the dynamic nature of the AI market [40][41]. 5. Investment Recommendations - The report suggests focusing on companies with successful AI product implementations, such as Jiahe Meikang and iFlytek, as well as those with promising technological advancements like Cambrian [11][47].

证券代码：688246 证券简称：嘉和美康 公告编号：2025-037 嘉和美康（北京）科技股份有限公司 2024年年度股东大会决议公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 本次会议是否有被否决议案：无 一、 会议召开和出席情况 （一） 股东大会召开的时间：2025 年 05 月 27 日 （二） 股东大会召开的地点：北京市海淀区东北旺西路 8 号院 28 号楼 1 层会议 室 （三） 出席会议的普通股股东、特别表决权股东、恢复表决权的优先股股东及 其持有表决权数量的情况： | 1、出席会议的股东和代理人人数 | 121 | | --- | --- | | 普通股股东人数 | 121 | | 2、出席会议的股东所持有的表决权数量 | 86,456,891 | | 普通股股东所持有表决权数量 | 86,456,891 | | 3、出席会议的股东所持有表决权数量占公司表决权数量的比 | 62.8386 | | 例（%） | | | 普通股股东所持有表决权数量占公司表决权数量的比例（%） | 62.83 ...

北京市中伦律师事务所 关于嘉和美康（北京）科技股份有限公司 2024 年年度股东大会的 法律意见书 二〇二五年五月 北京市中伦律师事务所 关于嘉和美康（北京）科技股份有限公司 2024 年年度股东大会的 法律意见书 致：嘉和美康（北京）科技股份有限公司 根据《中华人民共和国公司法》（以下简称《公司法》）、《中华人民共和国证 券法》（以下简称《证券法》）、中国证券监督管理委员会发布的《上市公司股东 会规则》（以下简称《股东会规则》）的规定，北京市中伦律师事务所（以下简称 "本所"）接受嘉和美康（北京）科技股份有限公司（以下简称"公司"）的委 托，指派本所律师出席公司 2024 年年度股东大会（以下简称"本次股东大会"）， 对本次股东大会的相关事项进行见证并出具法律意见。 为出具本法律意见书，本所律师审查了公司提供的相关文件，该等文件包括 但不限于： 1.现行有效的公司章程； 2.于 2025 年 4 月 30 日发布在上海证券交易所网站（www.sse.com.cn）上的 公司关于召开 2024 年年度股东大会的通知的公告； 3.公司本次股东大会股权登记日（2025 年 5 月 21 日）的股东名册； 1 一、 ...

证券代码：688246 证券简称：嘉和美康 公告编号：2025-036 嘉和美康（北京）科技股份有限公司 关于召开 2024 年度暨 2025 年第一季度业绩说明会的 公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 会议召开时间：2025 年 6 月 10 日(星期二)14:00-15:00 会 议 召 开 地 点 ： 上 海 证 券 交 易 所 上 证 路 演 中 心 （ 网 址 ： http://roadshow.sseinfo.com/） 会议召开方式：上证路演中心网络互动 投资者可于 2025 年 6 月 3 日(星期二)至 6 月 9 日(星期一)16:00 前登录上证 路演中心网站首页点击"提问预征集"栏目或通过公司邮箱 zqb@bjgoodwill.com 进行提问。公司将在说明会上对投资者普遍关注的问题进行回答。 嘉和美康（北京）科技股份有限公司（以下简称"公司"）已于 2025 年 4 月 30 日发布公司 2024 年年度报告和 2025 年第一季度报告，为便于广大投资者 更全面深 ...

Investment Rating - The report maintains a "Buy" rating for several companies in the computer and AI sectors, including Yidao Information, iFlytek, Weike Technology, and others [15][53]. Core Insights - The "Star Computing" plan, led by Guoxing Aerospace, successfully launched 12 space computing satellites, marking the beginning of a new era in space computing [5][6][23]. - OpenAI's release of the cloud-based AI programming agent Codex is set to revolutionize software development, enabling developers to complete tasks that previously took hours in just 30 minutes [8][29][31]. - Perplexity AI is nearing completion of a $500 million funding round, raising its valuation to $14 billion, reflecting strong growth in the AI search engine market [10][37]. Summary by Sections Computing Power Dynamics - The rental prices for computing power remain stable, with specific configurations priced as follows: Tencent Cloud A100-40G at 28.64 CNY/hour and Alibaba Cloud A100-80G at 34.74 CNY/hour [22][24]. - The "Star Computing" plan aims to establish a space-based intelligent computing infrastructure, with the first batch of satellites equipped for space computing and interconnectivity [6][25]. AI Application Dynamics - Kimi's average traffic increased by 9.94%, indicating growing interest in AI applications [28]. - OpenAI's Codex, powered by the codex-1 model, is designed to assist developers in various coding tasks, significantly enhancing productivity [29][31]. AI Financing Trends - Perplexity AI's upcoming funding round will increase its valuation from $9 billion to $14 billion, highlighting the rapid growth in AI startups [10][37]. - The company has over 15 million monthly active users and is generating nearly $100 million in annual recurring revenue [10][38]. Investment Recommendations - Tencent reported a 13% year-on-year revenue growth in Q1 2025, with significant contributions from AI initiatives [51]. - Companies to watch include Jiahe Meikang, iFlytek, and others that are positioned to benefit from advancements in AI and computing power [52].

Group 1 - The core viewpoint of the report is to summarize the sponsorship activities and compliance of Huatai United Securities in relation to the initial public offering (IPO) of Jiahe Meikang (Beijing) Technology Co., Ltd. on the Sci-Tech Innovation Board [1][3][10] - The issuer, Jiahe Meikang, has a registered capital of 137,585,598 yuan and was listed on December 14, 2021, with the stock code 688246.SH [1][3] - The total net proceeds from the IPO amounted to 1,240,457,179.15 yuan, which were allocated to various projects including electronic medical record development and operational funds [4][10] Group 2 - During the continuous supervision period, the sponsor conducted semi-annual inspections of the use and storage of raised funds, ensuring compliance with regulations [3][4] - The sponsor issued a total of 18 verification opinions regarding the issuer's use of raised funds and did not issue any dissenting opinions [4][10] - The issuer's shareholders, specifically the Xianning Kaixuan Opportunity Growth Fund, failed to timely fulfill commitments related to share reduction, leading to regulatory actions [5][7] Group 3 - The issuer discovered accounting errors in the financial statements for 2022 and 2023, which were corrected through retrospective adjustments approved by the board [10][11] - The sponsor confirmed that the issuer complied with relevant regulations in the use of raised funds and maintained proper disclosure practices [10][12] - As of December 31, 2024, the raised funds had not been fully utilized, and the sponsor will continue to oversee the usage until completion [12]